MARKET WIRE NEWS
  1. Home
  2. Stock
  3. QNRX
  4. News
QNRX
Quote
Short
News
Articles
Message Board

Quoin Pharmaceuticals Ltd. (NASDAQ : QNRX ) News

News Releases

QNRX News Releases
QNRX : NASDAQ
GlobeNewswire
Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI(TM) as the Proposed Brand Name for QRX003 for Netherton Syndrome
QNRX : NASDAQ
GlobeNewswire
Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003
QNRX : NASDAQ
GlobeNewswire
Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program
QNRX : NASDAQ
GlobeNewswire
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
QNRX : NASDAQ
SeekingAlpha
The Prognosis For Palvella Therapeutics
QNRX : NASDAQ
GlobeNewswire
Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome
QNRX : NASDAQ
SeekingAlpha
Quoin Pharmaceuticals GAAP EPS of -$1.77 beats by $0.25
QNRX : NASDAQ
GlobeNewswire
Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
QNRX : NASDAQ
GlobeNewswire
Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026
QNRX : NASDAQ
GlobeNewswire
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.